Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins.

PURPOSE Traditionally, portal images have been used for verification of patient setup. More recently, direct prostate localization using ultrasound imaging has become available. The aim of this study was to use both modalities to measure daily setup error and prostate organ motion and their respective contributions to the overall uncertainty of prostate target localization. METHODS AND MATERIALS Thirty-five patients treated for prostate cancer with intensity-modulated radiotherapy (IMRT) between February 6 and July 2, 2001 underwent daily B-mode acquisition and targeting (BAT) ultrasound localization and weekly orthogonal portal imaging. RESULTS A total of 243 pairs of orthogonal portal films and the corresponding daily BAT images were reviewed. The mean shift +/- standard deviation in the right-left (RL), AP, and superinferior (SI) directions was 0.035 +/- 2.8 mm, -0.23 +/- 3.0 mm, and -0.013 +/- 2.0 mm, respectively, for portal films and -0.82 +/- 3.2 mm, -1.4 +/- 6.4 mm and -1.7 +/- 6.4 mm, respectively, for BAT images taken on the same day as the portal films. The mean prostate organ motion measurements were -0.89 +/- 3.3 mm (RL), -1.3 +/- 5.7 mm (AP), and -1.6 +/- 6.4 mm (SI). Without BAT localization, organ motion would have caused the clinical target volume to move outside the planning target volume margin in 23.3-41.8% of the treatments. Margins necessary to achieve complete coverage of the clinical target volume > 95% of the time without BAT would have been 5.3, 10.4 and 10.4 mm in the RL, AP, and SI dimensions, respectively. CONCLUSIONS Prostate organ motion appears to predominate over setup error as the major component of variation in target localization. Without the use of BAT ultrasound prostate imaging, misses of the prostate can occur in a high percentage of treatments, despite patient setup verification with portal images. Relatively large planning target volume margins in the AP and SI dimensions may be necessary to overcome this.

[1]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[2]  P Kijewski,et al.  Analysis of prostate and seminal vesicle motion: implications for treatment planning. , 1996, International journal of radiation oncology, biology, physics.

[3]  Tanya M Powell,et al.  Independent prostate motion as measured by daily BAT ultrasound and electronic portal imaging , 2001 .

[4]  C. Pelizzari,et al.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[5]  G Morton,et al.  Target position variability throughout prostate radiotherapy. , 1998, International journal of radiation oncology, biology, physics.

[6]  M Wannenmacher,et al.  Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. , 1996, International journal of radiation oncology, biology, physics.

[7]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[8]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[9]  G J Kutcher,et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[10]  J A Antolak,et al.  Prostate target volume variations during a course of radiotherapy. , 1998, International journal of radiation oncology, biology, physics.

[11]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  C. Coleman,et al.  Analysis of prostate and seminal vesicle motion , 1993 .

[13]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[14]  T E Schultheiss,et al.  Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy. , 2000, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.

[15]  A. Hanlon,et al.  Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. , 2000, Urology.

[16]  C. Reddy,et al.  Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. , 2000, Urology.

[17]  Gary A Ezzell,et al.  Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[18]  P. Greer,et al.  Set-up variation of patients treated with radiotherapy to the prostate measured with an electronic portal imaging device. , 1998, Australasian radiology.

[19]  Prostate localization in prostate IMRT, advantage of bat over daily EPID , 2001 .

[20]  V. Althof,et al.  Variation in prostate position relative to adjacent bony anatomy. , 1996, International journal of radiation oncology, biology, physics.

[21]  M. Roach,et al.  Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. , 1997, Radiation oncology investigations.

[22]  J. Manola,et al.  A practical method to achieve prostate gland immobilization and target verification for daily treatment. , 2001, International journal of radiation oncology, biology, physics.

[23]  T E Schultheiss,et al.  Daily CT localization for correcting portal errors in the treatment of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[24]  G J Kutcher,et al.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.

[25]  A. Hanlon,et al.  Dose selection for prostate cancer patients based on dose comparison and dose response studies. , 2000, International journal of radiation oncology, biology, physics.

[26]  Evaluation of ultrasound-based daily prostate localization during IMRT for prostate cancer , 2001 .

[27]  H Alasti,et al.  Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. , 2001, International journal of radiation oncology, biology, physics.

[28]  D. Low,et al.  A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[29]  A Pollack,et al.  Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[30]  Lei Dong,et al.  Intrafraction prostate motion during IMRT for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[31]  E. B. Butler,et al.  Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. , 2001, International journal of radiation oncology, biology, physics.

[32]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[33]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[34]  D. Kuban,et al.  High-dose intensity modulated radiation therapy for prostate cancer , 2004, Current urology reports.

[35]  M van Herk,et al.  Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[37]  G J Kutcher,et al.  Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. , 1997, International journal of radiation oncology, biology, physics.